This study investigates the factors responsible for the poor performance of 67 electric utilities in 47 countries, using ...

Discover long-term income opportunities as the market fixates on AI. Learn strategies for building a resilient, ...

Total product sales -- $7.3 billion in fiscal Q3 2025, up 4% sequentially from Q2 2025, with growth driven by the HIV ...

Good day, ladies and gentlemen, and welcome to the Block Third Quarter 2025 Earnings Conference Call. Today's call will be 45 minutes. I would now like to turn the call over to your host, Matt Ross, ...

Gross margin for 2025 was 31.8% (non-GAAP), up from 28.8% in 2024, at the upper end of the company’s targeted 27%-32% range (non-GAAP) for 2025. Operating Expenses -- Operating expenses for 2025 were ...

Here are the top medical news for the dayCitrus and Grape Compounds Could Help Prevent Type 2 Diabetes, Study FindsScientists have found that a novel food supplement containing citrus and red ...

A RECENT Greek study presented at EASD 2025 has suggested that semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, provides strong protection against diabetic retinopathy, the leading ...

Q3 2025 Earnings Call Transcript October 28, 2025 Operator: Ladies and gentlemen, thank you for joining us, and welcome to ...

Wearables, Mobile Health (m-Health), Real-Time Monitoring Share and Cite: Alqarni, A. (2025) Analysis of Decision Support ...

Objective The left atrial stiffness index (LASI) has been proven to be a promising marker for assessing left atrial (LA) and ...

Profit for the period was €22 million, a decrease of €15 million, compared to €37 million in the same quarter in 2024, as strong operating results were offset principally by a €22 million lower ...

Record free cash flow of approximately $700 million and achieved net cash position Increased 2025 share buyback target by 20% to $600 million and ...